SCHEMBL5371871

SCHEMBL5371871

COC(=O)c1cc(S(=O)(=O)Nc2ccc(-c3ccc(C(F)(F)F)cc3)cc2)ccc1C

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.57
ALOX15 P16050 1/20 0.57
MAPK1 P28482 1/20 0.57
KMT2A Q03164 1/20 0.57
POLB P06746 1/20 0.55
BRD4 O60885 1/20 0.52
IDH1 O75874 4/20 0.51
PLAU P00749 4/20 0.50
PLAT P00750 1/20 0.50
KDM1A O60341 1/20 0.49
AVPR2 P30518 1/20 0.48
GPR27 Q9NS67 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
HSD17B2 P37059 1/20 0.48
KIF11 P52732 1/20 0.48
MAPT P10636 1/20 0.47
CYP2D6 P10635 1/20 0.47
PSEN1 P49768 1/20 0.47
PSEN2 P49810 1/20 0.47
APH1B Q8WW43 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5372103 0.93 POLB (0.53) MEN1ALOX15MAPK1KMT2APOLB
SCHEMBL5376420 0.91 PLAU (0.64) MEN1ALOX15MAPK1KMT2APOLB
SCHEMBL5378704 0.90 POLB (0.56) MEN1KMT2APOLBIDH1PLAU
SCHEMBL5373250 0.88 POLB (0.63) MEN1ALOX15MAPK1KMT2APOLB
SCHEMBL5368389 0.88 POLB (0.60) POLBIDH1PLAUPLATSMN1; SMN2
SCHEMBL5382304 0.87 MEN1 (0.55) MEN1ALOX15MAPK1KMT2ABRD4
SCHEMBL5380693 0.86 POLB (0.62) MEN1MAPK1KMT2APOLBPLAU
SCHEMBL4895869 0.86 MAPK1 (0.49) MEN1ALOX15MAPK1KMT2APOLB
SCHEMBL5368417 0.85 ALOX15 (0.48) MEN1ALOX15MAPK1KMT2APOLB
SCHEMBL5386615 0.84 POLB (0.50) MEN1ALOX15MAPK1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PFIZER INC 2006-11-16 US disclosed
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD MEN1 4855/4885ALOX15 1494/4885MAPK1 3366/4885
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARG, PPARA, PPARD MEN1 4861/4885ALOX15 1818/4885MAPK1 3481/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.